FN-C1q and C1 INH Clr-Cls complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia

Tünde Hidvégi, Gennadi A. Ermolin, Evgeni E. Efremov, Michail M. Dikov, Ludmilla V. Kurmanova, Galina V. Vnashenkova, Marina V. Merkulova, Márta Kókai, Aranka Panya, G. Füst

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We have previously found low levels of C1 and C4 INH in the sera of chronic lymphocytic leukaemia (CLL) patients. Hypocomplementaemia was supposed to be the consequence of a permanent activation of the classical pathway. We have compared the levels of C1 INH-C1rC1s and C1q-FN complexes in the sera of 95 CLL patients and 100 healthy controls, because these complexes are known to be formed in the early stage of classical pathway activation. A significant increase in the level of both types of complexes was found in sera of CLL patients as compared to the controls. These findings support the assumption that the classical complement pathway is activated in the patients with CLL.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalImmunology Letters
Volume22
Issue number1
DOIs
Publication statusPublished - 1989

Fingerprint

Complement Activation
B-Cell Chronic Lymphocytic Leukemia
Serum
Classical Complement Pathway

Keywords

  • C1 INH
  • C1rC1s
  • CLL
  • FN-C1q complexes
  • Hypocomplementaemia

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

FN-C1q and C1 INH Clr-Cls complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia. / Hidvégi, Tünde; Ermolin, Gennadi A.; Efremov, Evgeni E.; Dikov, Michail M.; Kurmanova, Ludmilla V.; Vnashenkova, Galina V.; Merkulova, Marina V.; Kókai, Márta; Panya, Aranka; Füst, G.

In: Immunology Letters, Vol. 22, No. 1, 1989, p. 1-6.

Research output: Contribution to journalArticle

Hidvégi, T, Ermolin, GA, Efremov, EE, Dikov, MM, Kurmanova, LV, Vnashenkova, GV, Merkulova, MV, Kókai, M, Panya, A & Füst, G 1989, 'FN-C1q and C1 INH Clr-Cls complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia', Immunology Letters, vol. 22, no. 1, pp. 1-6. https://doi.org/10.1016/0165-2478(89)90133-8
Hidvégi, Tünde ; Ermolin, Gennadi A. ; Efremov, Evgeni E. ; Dikov, Michail M. ; Kurmanova, Ludmilla V. ; Vnashenkova, Galina V. ; Merkulova, Marina V. ; Kókai, Márta ; Panya, Aranka ; Füst, G. / FN-C1q and C1 INH Clr-Cls complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia. In: Immunology Letters. 1989 ; Vol. 22, No. 1. pp. 1-6.
@article{b582359e09c34f77b320f555345dca2d,
title = "FN-C1q and C1 INH Clr-Cls complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia",
abstract = "We have previously found low levels of C1 and C4 INH in the sera of chronic lymphocytic leukaemia (CLL) patients. Hypocomplementaemia was supposed to be the consequence of a permanent activation of the classical pathway. We have compared the levels of C1 INH-C1rC1s and C1q-FN complexes in the sera of 95 CLL patients and 100 healthy controls, because these complexes are known to be formed in the early stage of classical pathway activation. A significant increase in the level of both types of complexes was found in sera of CLL patients as compared to the controls. These findings support the assumption that the classical complement pathway is activated in the patients with CLL.",
keywords = "C1 INH, C1rC1s, CLL, FN-C1q complexes, Hypocomplementaemia",
author = "T{\"u}nde Hidv{\'e}gi and Ermolin, {Gennadi A.} and Efremov, {Evgeni E.} and Dikov, {Michail M.} and Kurmanova, {Ludmilla V.} and Vnashenkova, {Galina V.} and Merkulova, {Marina V.} and M{\'a}rta K{\'o}kai and Aranka Panya and G. F{\"u}st",
year = "1989",
doi = "10.1016/0165-2478(89)90133-8",
language = "English",
volume = "22",
pages = "1--6",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - FN-C1q and C1 INH Clr-Cls complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia

AU - Hidvégi, Tünde

AU - Ermolin, Gennadi A.

AU - Efremov, Evgeni E.

AU - Dikov, Michail M.

AU - Kurmanova, Ludmilla V.

AU - Vnashenkova, Galina V.

AU - Merkulova, Marina V.

AU - Kókai, Márta

AU - Panya, Aranka

AU - Füst, G.

PY - 1989

Y1 - 1989

N2 - We have previously found low levels of C1 and C4 INH in the sera of chronic lymphocytic leukaemia (CLL) patients. Hypocomplementaemia was supposed to be the consequence of a permanent activation of the classical pathway. We have compared the levels of C1 INH-C1rC1s and C1q-FN complexes in the sera of 95 CLL patients and 100 healthy controls, because these complexes are known to be formed in the early stage of classical pathway activation. A significant increase in the level of both types of complexes was found in sera of CLL patients as compared to the controls. These findings support the assumption that the classical complement pathway is activated in the patients with CLL.

AB - We have previously found low levels of C1 and C4 INH in the sera of chronic lymphocytic leukaemia (CLL) patients. Hypocomplementaemia was supposed to be the consequence of a permanent activation of the classical pathway. We have compared the levels of C1 INH-C1rC1s and C1q-FN complexes in the sera of 95 CLL patients and 100 healthy controls, because these complexes are known to be formed in the early stage of classical pathway activation. A significant increase in the level of both types of complexes was found in sera of CLL patients as compared to the controls. These findings support the assumption that the classical complement pathway is activated in the patients with CLL.

KW - C1 INH

KW - C1rC1s

KW - CLL

KW - FN-C1q complexes

KW - Hypocomplementaemia

UR - http://www.scopus.com/inward/record.url?scp=0024356868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024356868&partnerID=8YFLogxK

U2 - 10.1016/0165-2478(89)90133-8

DO - 10.1016/0165-2478(89)90133-8

M3 - Article

C2 - 2550362

AN - SCOPUS:0024356868

VL - 22

SP - 1

EP - 6

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1

ER -